Patents by Inventor Irene Pasquali

Irene Pasquali has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dry powder inhaler and inhalation actuated mechanism thereof
    Patent number: 11167097
    Abstract: A flap (20) for an inhalation actuated mechanism (18) of a powder inhaler (1) comprises a base member (29), a skirt structure (24) projecting from a surface of the base member (29), and a coupling portion (21) to be coupled to a resilient member (40?) of the inhalation actuated mechanism (18).
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: November 9, 2021
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Valerio Tampieri, Lorenzo Zuccheri, Emiliano Ilandi, Alice Campanini, Irene Pasquali, Patrick Gerard Linnane, Nicholas Lee Hawson, David Gale, Joanne Garrad
  • Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 10946029
    Abstract: Compositions comprising a corticosteroid and a beta-adrenergic are useful for treating inflammatory or obstructive airways diseases.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: March 16, 2021
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisa Monari, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali
  • DRY POWDER INHALER AND INHALATION ACTUATED MECHANISM THEREOF
    Publication number: 20200230331
    Abstract: A flap (20) for an inhalation actuated mechanism (18) of a powder inhaler (1) comprises a base member (29), a skirt structure (24) projecting from a surface of the base member (29), and a coupling portion (21) to be coupled to a resilient member (40?) of the inhalation actuated mechanism (18).
    Type: Application
    Filed: February 6, 2019
    Publication date: July 23, 2020
    Inventors: Valerio Tampieri, Lorenzo Zuccheri, Emiliano Ilandi, Alice Campanini, Irene Pasquali, Patrick Gerard Linnane, Nicholas Lee Hawson, David Gale, Joanne Garrad
  • DRY POWDER INHALER AND INHALATION ACTUATED MECHANISM THEREOF
    Publication number: 20190167925
    Abstract: A flap (20) for an inhalation actuated mechanism (18) of a powder inhaler (1) comprises a base member (29), a skirt structure (24) projecting from a surface of the base member (29), and a coupling portion (21) to be coupled to a resilient member (40?) of the inhalation actuated mechanism (18).
    Type: Application
    Filed: February 6, 2019
    Publication date: June 6, 2019
    Inventors: Valerio Tampieri, Lorenzo Zuccheri, Emiliano Ilandi, Alice Campanini, Irene Pasquali, Patrick Gerard Linnane, Nicholas Lee Hawson, David Gale, Joanne Garrad
  • Dry powder inhaler and inhalation actuated mechanism thereof
    Patent number: 10238819
    Abstract: A flap (20) for an inhalation actuated mechanism (18) of a powder inhaler (1) comprises a base member (29), a skirt structure (24) projecting from a surface of the base member (29), and a coupling portion (21) to be coupled to a resilient member (40?) of the inhalation actuated mechanism (18).
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: March 26, 2019
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Valerio Tampieri, Lorenzo Zuccheri, Emiliano Ilandi, Alice Campanini, Irene Pasquali, Patrick Gerard Linnane, Nicholas Lee Hawson, David Gale, Joanne Garrad
  • DRY POWDER FORMULATION COMPRISING A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20180296573
    Abstract: Compositions comprising a corticosteroid and a beta-adrenergic are useful for treating inflammatory or obstructive airways diseases.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 18, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisa MONARI, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali
  • Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 10028964
    Abstract: The invention relates to a dry powder formulation comprising corticosteroid and a beta2-adrenergic drug in combination, its process preparation, and therapeutic uses thereof.
    Type: Grant
    Filed: January 23, 2013
    Date of Patent: July 24, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisa Monari, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali
  • Particle size reduction of an antimuscarinic compound
    Patent number: 9889094
    Abstract: A stable crystalline micronized particulate of a glycopyrronium salt may be prepared by suspending the drug in a water-immiscible anti-solvent in which the drug has little or no solubility and micronizing the suspension. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: February 13, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene Pasquali, Andrea Casazza, Elena Losi, Mark Saunders
  • Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 9808422
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: November 7, 2017
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Irene Pasquali, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • PARTICLE SIZE REDUCTION OF AN ANTIMUSCARINIC COMPOUND
    Publication number: 20160279066
    Abstract: A stable crystalline micronized particulate of a glycopyrronium salt may be prepared by suspending the drug in a water-immiscible anti-solvent in which the drug has little or no solubility and micronizing the suspension. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Application
    Filed: June 10, 2016
    Publication date: September 29, 2016
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Andrea CASAZZA, Elena LOSI, Mark SAUNDERS
  • DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20160263027
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 9402825
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: August 2, 2016
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Irene Pasquali, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • Particle size reduction of an antimuscarinic compound
    Patent number: 9393202
    Abstract: A stable crystalline micronized particulate of a glycopyrronium salt may be prepared by suspending the drug in a water-immiscible anti-solvent in which the drug has little or no solubility and micronizing the suspension. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: July 19, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A
    Inventors: Irene Pasquali, Andrea Casazza, Elena Losi, Mark Saunders
  • DRY POWDER INHALER AND INHALATION ACTUATED MECHANISM THEREOF
    Publication number: 20150374937
    Abstract: A flap (20) for an inhalation actuated mechanism (18) of a powder inhaler (1) comprises a base member (29), a skirt structure (24) projecting from a surface of the base member (29), and a coupling portion (21) to be coupled to a resilient member (40?) of the inhalation actuated mechanism (18).
    Type: Application
    Filed: June 30, 2015
    Publication date: December 31, 2015
    Inventors: Valerio Tampieri, Lorenzo Zuccheri, Emiliano Ilandi, Alice Campanini, Irene Pasquali, Patrick Gerard Linnane, Nick Hawson, David Gale, Joanne Garrard
  • DRY POWDER FORMULATION COMPRISING A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20150164915
    Abstract: The invention relates to a dry powder formulation comprising corticosteroid and a beta2-adrenergic drug in combination, its process preparation, and therapeutic uses thereof.
    Type: Application
    Filed: January 23, 2013
    Publication date: June 18, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisa Monari, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali
  • DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20150017248
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Application
    Filed: July 10, 2014
    Publication date: January 15, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • PARTICLE SIZE REDUCTION OF AN ANTIMUSCARINIC COMPOUND
    Publication number: 20140322142
    Abstract: A stable crystalline micronized particulate of a glycopyrronium salt may be prepared by suspending the drug in a water-immiscible anti-solvent in which the drug has little or no solubility and micronizing the suspension. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Application
    Filed: April 22, 2014
    Publication date: October 30, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Andrea Casazza, Elena Losi, Mark Saunders
  • Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
    Patent number: 8778402
    Abstract: Dry powder formulations comprising a corticosteroid and a beta2-adrenergic drug in combination are useful for the prevention and/or treatment of inflammatory or obstructive airways diseases.
    Type: Grant
    Filed: January 24, 2013
    Date of Patent: July 15, 2014
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Elisa Monari, Anna Maria Cantarelli, Daniela Cocconi, Irene Pasquali